Bioasis Technologies Inc. V.BTI

Prothena

[AlfredSisley]

https://ir.prothena.com/news-releases/news-release-details/prothena-announces-promising-new-preclinical-and-clinical-data

https://www.prothena.com/pipeline/

[Finallytherock]

What does this have to do with us? Are we involved with this program? 

[AlfredSisley]

No idea. We know very little about the deal with prothena other than it's preclinical and in neuroscience. Given the agreement between Bioasis and Prothena was extended to the end of Q1 2021, believe it's worthwile keeping an eye on them. Fingers crossed for some positive news.

[regardless]

Alfredsisley i agree.... extending the bioasis deal for three months is what you do when you expect results in three months time....so it made sense to extend them and wait and see approach.... now finally we may have something here and i am looking forward to hearing what prothena has to say...and hopefully they say our name for a change 

[barsax]

One of the payload modalities of the xB3 platform are antibodies.  I have no idea if the Prothena antibody in this instance uses the xB3 platform to get across the BBB: Title: Microtubule Binding Region (MTBR)-Specific Antibody PRX005 Prevents Pathological Tau Progression Via Blockade of Neuronal Internalization Session: Tau Pathology and Therapeutic Strategies 1 Date